location:Home > 2020 Vol.1 Jun.  No.2 > Clinical analysis of nonspecific orbital inflammation in adults and children

2020 Vol.1 Jun.  No.2

  • Title: Clinical analysis of nonspecific orbital inflammation in adults and children
  • Name: Toyotomi Hideyoshi1, Air Sea 2
  • Company: (1.Chiba University of Science,Cho Tzu 288-0872,Japan; 2.Jibei International University,High beam716-0009,Japan)
  • Abstract:

    Objective To study the therapeutic effect of non-specific orbital inflammation (NSOI) in adults and children. Methods 114 cases of NSOI were analyzed retrospectively, 54 cases were male (47.37%), 60 cases were female (52.63%), the age range was 6-72 years. The disease characteristics of adult group and children group were studied respectively. The patients were divided into 9 groups according to the involved site and histopathological results. Including: anterior orbital inflammatory type, lacrimal gland inflammatory type, myositis type, perioptic neuritis type, acute fat type, mass type, orbital apex type, diffuse type and mixed type; according to the course of disease, it can be divided into acute, subacute and chronic. Among them, those with symptoms lasting less than 1 week are acute, those with symptoms lasting from 1 week to 1 month are subacute, and those with symptoms lasting more than 1 month are chronic. All patients were followed up for 2 months. Results Among the 9 groups, lacrimal gland inflammation was the most common type (44 cases, 38.60%); acute non-specific orbital inflammation was the most common type (50%). During the follow-up period, 14 patients (12.28%) recurred. Conclusion Clinical characteristics of NSOI are different between adults and children, and the therapeutic effect of corticosteroid is obvious.


  • Keyword: nonspecific orbital inflammation; histology; corticosteroids
  • DOI: 10.12250/jpcarme2020010287
  • Citation form: Toyotomi Hideyoshi, Air Sea.Clinical analysis of nonspecific orbital inflammation in adults and children.2020,Vol.1,16-20.
Reference:

[1] Kitei D, DiMario FJ. Childhood orbital pseudotumor: case report and literature review. J Child Neurol. 2008, 23(4):425-430.

[2]  Zborowska B, Ghabrial R, Selva D, McCluskey P. Idiopathic orbital inflflammation with extraorbital extension: case series and review. Eye (Lond). 2006, 20(1):107-113.

[3]Yan J, Qiu H, Wu Z, Li Y. Idiopathic orbital inflflammatory pseudotumor in Chinese children. Orbit. 2006;25(1):1-4.

[4] Gordon LK. Orbital inflflammatory disease: a diagnostic and therapeutic

challenge. Eye (Lond). 2006;20(10):1196-1206.

[5]Rosenbaum J T, Choi D, Harrington C A, et al. Gene Expression Profiling and Heterogeneity of Nonspecific Orbital Inflammation Affecting the Lacrimal Gland.[J]. Jama Ophthalmol, 2017, 135(11):1156-1159.

[6]Braich P S, Kuriakose R K, Khokhar N S, et al. Factors associated with multiple recurrences of nonspecific orbital inflammation aka orbital pseudotumor[J]. International Ophthalmology, 2017, 38(16 ):1-11.

[7]Callahan A B, Scofield S M, Gallin P F, et al. Retained strabismus suture material masquerading as nonspecific orbital inflammation[J]. Journal of Aapos, 2016, 20(3):280-282.

[8]Jakobiec F A, Syed Z A, Stagner A M, et al. Orbital Inflammation in Pregnant Women[J]. American Journal of Ophthalmology, 2016, 166:91-102.

[9] Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L. What is orbital pseudotumor? Surv Ophthalmol. 1996;41(1):66-78.

[10] Rootman J, Nugent R. The classifification and management of acute orbital pseudotumors. Ophthalmology. 1982;89(9):1040-1048.

[11] Fujii H, Fujisada H, Kondo T, Takahashi T, Okada S. Orbital pseudotumor: histopathological classifification and treatment. Ophthalmologica. 1985;190(4):230-242.

[12] Spindle J, Tang SX, Davies B, et al. Pediatric idiopathic orbital inflflammation: clinical features of 30 cases. Ophthal Plast Reconstr Surg. 2016; 32(4):270-274.

[13]Harris GJ. Idiopathic orbital inflflammation: a pathogenetic construct and treatment strategy: the 2005 ASOPRS Foundation Lecture. Ophthal Plast Reconstr Surg. 2006;22(2):79-86.

[14]Ho VH, Chevez-Barrios P, Jorgensen JL, Silkiss RZ, Silkis RZ, Esmaeli B. Receptor expression in orbital inflflammatory syndromes and implications for targeted therapy. Tissue Antigens. 2007;70(2):105-109.

[15]Swamy BN, McCluskey P, Nemet A, et al. Idiopathic orbital inflflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol. 2007;91(12):1667-1670.

[16]Misselwitz B, Epprecht J, Mertens J, et al. Orbital pseudotumor as a rare extrahepatic manifestation of hepatitis C infection. Case Rep Gastroenterol. 2016;10(1):108-114.

[17]Yan J, Wu Z, Li Y. [36 case idiopathic orbital inflammatory pseudotumor with sinus involvement][J]. Journal of Clinical Otorhinolaryngology, 2002, 16(8):410-411.

 


Tsuruta Institute of Medical Information Technology
Address:[502,5-47-6], Tsuyama, Tsukuba, Saitama, Japan TEL:008148-28809 fax:008148-28808 Japan,Email:jpciams@hotmail.com,2019-09-16